Washington, DC – Rep. Peter Welch (D-Vt.) along with Rep.
Rep. Peter Welch (D-Vt.) issued the following statement on President Trump’s State of the Union Address:
“It’s good that the President called for unity tonight. But when the President who calls for unity is the one who has spent his presidency sowing discord—yes, I’d like to be hopeful—but I am deeply skeptical.
WASHINGTON—Rep. Peter Welch (D-Vt.) and Rep. David McKinley (R-W.Va.) today introduced the Fair Access for Safe and Timely (FAST) Generics Act. The legislation would thwart manipulation of the Food and Drug Administration’s (FDA) drug safety regulations in order to block the production of generic alternatives to brand name medicines.
Rep. Peter Welch (D-Vt.) issued the following statement on the reopening of federal government:
Bipartisan bill protects community pharmacies and Medicare Part D beneficiaries
WASHINGTON, D.C. – Reps. Peter Welch (D-Vt.) and Morgan Griffith (R-Va.) today reintroduced the Improving Transparency and Accuracy in Medicare Part D Drug Spending Act.
WASHINGTON - Rep. Peter Welch (D-Vt.) has been reappointed to the House Committee on Oversight and Reform. The committee has broad jurisdiction over executive branch programs and activities. Welch has served on the committee since he was first elected to Congress in 2006.
SOUTH BURLINGTON – Before boarding a flight at Burlington International Airport this morning to return to Washington, Rep. Peter Welch (D-Vt.) unveiled legislation that will put an end to the practice of requiring federal employees to work without pay during the current or any future government shutdown.
Reappointed to Democratic leadership team; Secures key subcommittee assignments on powerful House Energy and Commerce Committee
WASHINGTON – Rep. Peter Welch (D-Vt.) took to the House floor today to call for an end to the 25-day partial government shutdown and share the stories of affected Vermonters ranging from furloughed federal employees struggling to pay their bills to those unable to access to critical government services.
WASHINGTON – Reps. Peter Welch (D-Vt.) and Francis Rooney (R-Fla.) sent a letter late Friday to federal regulators demanding scrutiny of the impact on consumers of the pending merger of two pharmaceutical giants, Celgene and Bristol-Myers Squibb.